FLT3 and acute myeloid leukemia: Early studies with mutated FLT3-ITD degraders showed significant inhibition of FLT3-ITD-positive cells growth, as well as downregulation of the phosphorylation of FLT3 and STAT5, which are key downstream molecules involved in AML pathogenesis [178].